SCHEMBL624434

SCHEMBL624434

CN(C)c1cccc(-c2cn3nc(N(C)CC4CCN(C(=O)OC(C)(C)C)CC4)sc3n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.48
JAK3 P52333 1/20 0.48
PTK2 Q05397 1/20 0.48
USP30 Q70CQ3 3/20 0.42
TGFBR1 P36897 1/20 0.41
GPR119 Q8TDV5 5/20 0.38
SCN9A Q15858 1/20 0.38
LIMK2 P53671 1/20 0.37
KDM4E B2RXH2 3/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
TSHR P16473 2/20 0.37
KMT2A Q03164 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MMP1 P03956 1/20 0.37
MMP13 P45452 1/20 0.37
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625331 0.88 PIM1 (0.45) JAK2JAK3PTK2GPR119SCN9A
SCHEMBL624058 0.85 JAK2 (0.47) JAK2JAK3PTK2USP30TGFBR1
SCHEMBL624433 0.83 FYN (0.47) JAK2JAK3PTK2USP30TGFBR1
SCHEMBL624904 0.81 F2RL3 (0.41) JAK2JAK3PTK2KDM4EHSD17B10
SCHEMBL627188 0.80 GPR119 (0.40) GPR119LIMK2KDM4EHPGDMAPT
SCHEMBL628029 0.72 F2RL3 (0.49) TGFBR1GPR119SCN9AKDM4EMEN1
SCHEMBL626983 0.72 CETP (0.44) JAK2JAK3PTK2GPR119KDM4E
SCHEMBL625330 0.71 PIM1 (0.52)
SCHEMBL624533 0.71 PIM1 (0.53) KDM4EMAPTPKM
SCHEMBL624009 0.70 PIM1 (0.44) GAAMAPTF2RL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020217-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed